Go Pro

Damora Therapeutics, Inc. Common Stock (DMRA) Short Interest Ratio & Short Volume

Damora Therapeutics, Inc. Common Stock logo
$29.00 -1.60 (-5.23%)
As of 08/28/2026 04:00 PM Eastern

Damora Therapeutics, Inc. Common Stock Short Interest Overview

As of August 14, 2026, Damora Therapeutics, Inc. Common Stock (DMRA) had a short interest of 4.74 million shares sold short, representing 7.71% of the public float. This marks a -3.14% decrease in short interest since the prior report. The short interest ratio (days to cover) is 13.6, meaning it would take 13.6 days of the average trading volume of 325,489 shares to cover all short positions.

Current Short Interest
4,739,939 shares
Previous Short Interest
4,893,454 shares
Change Vs. Previous Month
-3.14%
Dollar Volume Sold Short
$147.13 million
Short Interest Ratio
13.6 Days to Cover
Last Record Date
August 14, 2026
Outstanding Shares
61,740,000 shares
Short Percent of Float
7.71%
Today's Trading Volume
371,724 shares
Average Trading Volume
325,489 shares
Today's Volume Vs. Average
114%
Short Selling Damora Therapeutics, Inc. Common Stock?
A Guide To High-Short-Interest Stocks

Sign up to receive the latest short interest report for Damora Therapeutics, Inc. Common Stock and its competitors with MarketBeat's FREE newsletter.

Get Report
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Short Interest History

DMRA Short Interest Over Time

DMRA Days to Cover Over Time

DMRA Percentage of Float Shorted Over Time

Damora Therapeutics, Inc. Common Stock Tesla Short Interest History & Recent Changes

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
8/14/20264,739,939 shares $147.13 million -3.1%7.7%13.57 $31.04
7/31/20264,893,454 shares $141.86 million +4.4%8.0%11.71 $28.99
7/15/20264,688,241 shares $145.10 million +31.4%7.6%8.08 $30.95
6/30/20263,567,900 shares $92.80 million +172.3%5.8%2.63 $26.01
6/15/20261,310,364 shares $26.30 million -6.6%2.1%3.37 $20.07
5/29/20261,402,988 shares $34.91 million +8.7%2.3%4.14 $24.88
5/15/20261,290,741 shares $31.75 million +8.4%2.1%3.09 $24.60
4/30/20261,191,070 shares $30.56 million +6.7%2.0%5.51 $25.66
4/15/20261,116,620 shares $29.71 million +35.0%1.8%4.72 $26.61
3/31/2026827,221 shares $21.43 million +93.4%1.3%2.46 $25.90
3/13/2026427,713 shares $12.19 million +31.6%0.8%1.94 $28.50
2/27/2026325,076 shares $9.62 million +17.4%22.7%1.13 $29.58
2/13/2026277,004 shares $8.07 million +86.6%19.4%0.6 $29.12
1/30/2026148,474 shares $3.90 million -12.3%10.4%4.56 $26.24
1/15/2026169,350 shares $4.06 million -1.8%11.8%6.28 $23.95
12/31/2025172,444 shares $3.97 million -4.8%12.1%2.31 $23.01
12/15/2025181,086 shares $5.72 million +8.1%12.7%1.15 $31.60
11/28/2025167,465 shares $2.90 million -50.4%14.1%0.8 $17.35
11/14/2025337,430 shares $9.05 million +920.8%28.5%0.05 $26.83
10/31/202533,054 shares $241.96 thousand -62.9%2.8%0.33 $7.32
10/15/202589,100 shares $1.04 million -32.1%7.1%0 $11.68
9/30/2025131,200 shares $488.06 thousand +57.7%11.3%0.1 $3.72
9/15/202583,200 shares $235.46 thousand +560.3%7.3%0.1 $2.83
8/31/202512,600 shares $40.02 thousand -34.4%1.1%0.1 $3.18
8/15/202519,200 shares $65.38 thousand -30.2%1.7%0.9 $3.41
7/31/202527,500 shares $90.61 thousand -30.6%2.4%0.6 $3.30
7/15/202539,600 shares $140.58 thousand +7.3%3.5%0.9 $3.55
6/30/202536,900 shares $125.83 thousand -18.0%3.2%0.8 $3.41
6/15/202545,000 shares $150.75 thousand -40.4%4.0%0.5 $3.35
5/31/202575,500 shares $234.81 thousand +36.3%6.6%0.3 $3.11
5/15/202555,400 shares $161.21 thousand -20.4%4.9%0.2 $2.91
4/30/202569,600 shares $194.88 thousand +20.8%6.1%0.3 $2.80
4/15/202557,600 shares $148.03 thousand -11.0%5.1%0.2 $2.57
3/31/202564,700 shares $200.57 thousand +133.6%5.7%0.3 $3.10
3/15/202527,700 shares $112.19 thousand +51.4%2.4%0.1 $4.05
2/28/202518,300 shares $80.15 thousand -10.3%1.6%1 $4.38
2/15/202520,400 shares $97.51 thousand +56.9%1.8%1 $4.78
1/31/202513,000 shares $65 thousand -27.4%1.1%0.7 $5.00
1/15/202517,900 shares $86.28 thousand +6.6%1.6%0.9 $4.82
12/31/202416,800 shares $78.12 thousand -30.9%1.5%0.8 $4.65
The retirement stock I'd buy before Nvidia today (Ad)

In 2014, Marc Chaikin pointed readers toward Nvidia. Now the 60-year Wall Street veteran and creator of the Chaikin Money Flow indicator has a new top retirement pick. The company holds three fast-growing businesses -- including an autonomous vehicle unit and a streaming service with 10x Netflix's reach -- any of which could be spun off in the next 12 to 24 months. It also pays a dividend, a rarity among high-growth AI names. Chaikin lays out the full case in a new free presentation, no email or credit card required.tc pixel

Get Marc Chaikin's free presentation on this overlooked AI stock now
12/15/202424,300 shares $123.44 thousand +20.3%2.1%0.9 $5.08
11/30/202420,200 shares $107.06 thousand +112.6%1.8%0.7 $5.30
11/15/20249,500 shares $60.42 thousand +97.9%0.8%0.2 $6.36
10/31/20244,800 shares $32.88 thousand -48.9%0.4%0.1 $6.85
10/15/20249,400 shares $63.26 thousand -36.1%0.9%0.3 $6.73
9/30/202414,700 shares $178.61 thousand +129.7%1.4%0.5 $12.15
9/15/20246,400 shares $82.75 thousand -62.1%0.6%0.3 $12.93
8/31/202416,900 shares $201.96 thousand +98.8%1.9%1 $11.95
8/15/20248,500 shares $4.68 thousand +3.7%0.0%0.1 $0.55
7/31/20248,200 shares $4.62 thousand +173.3%0.0%0.1 $0.56
7/15/20243,000 shares $1.77 thousand -90.3%0.0%0 $0.59
6/30/202430,800 shares $14.61 thousand +1,084.6%0.2%0.2 $0.47
6/15/20242,600 shares $1.38 thousand -72.0%0.0%0 $0.53
5/31/20249,300 shares $5.65 thousand -80.4%0.1%0.1 $0.61
5/15/202447,400 shares $30.14 thousand -44.4%0.2%0.3 $0.64
4/30/202485,300 shares $58.77 thousand +373.9%0.4%0.4 $0.69
4/15/202418,000 shares $12.37 thousand -42.9%0.1%0.1 $0.69
3/31/202431,500 shares $24.57 thousand +74.0%0.2%0.1 $0.78
3/15/202418,100 shares $14.80 thousand -66.9%0.1%0 $0.82
2/29/202454,600 shares $39.32 thousand +39.6%0.3%0.1 $0.72
2/15/202439,100 shares $26.60 thousand -40.5%0.2%0.1 $0.68
1/31/202465,700 shares $40.21 thousand -53.0%0.3%0.2 $0.61
1/15/2024139,800 shares $96.18 thousand -54.3%0.7%0.4 $0.69
12/31/2023306,000 shares $220.32 thousand +332.2%1.6%0.8 $0.72
12/15/202370,800 shares $43.05 thousand -61.4%0.4%0.1 $0.61
11/30/2023183,400 shares $115.54 thousand -26.1%1.0%0.4 $0.63
11/15/2023248,000 shares $152.05 thousand -46.5%1.3%0.5 $0.61
10/31/2023463,900 shares $245.91 thousand -32.6%2.4%0.7 $0.53
10/15/2023688,500 shares $425.15 thousand -53.8%3.5%0.9 $0.62
9/30/20231,490,000 shares $1.07 million +337.5%7.0%2 $0.72
9/15/2023340,600 shares $201.87 thousand +95.8%1.6%0.7 $0.59
8/31/2023174,000 shares $105.27 thousand -55.9%0.8%0.4 $0.61
8/15/2023394,500 shares $265.70 thousand +73.0%2.0%1 $0.67
7/31/2023228,100 shares $702.55 thousand +403.5%1.2%1.3 $3.08
7/15/202345,300 shares $108.72 thousand -4.0%0.3%0.4 $2.40
6/30/202347,200 shares $118.94 thousand +271.7%0.3%0.7 $2.52
6/15/202312,700 shares $27.94 thousand +4.1%0.1%0.2 $2.20
5/31/202312,200 shares $26.60 thousand +3.4%0.1%0.2 $2.18
5/15/202311,800 shares $25.25 thousand -3.3%0.1%0.2 $2.14
4/30/202312,200 shares $21.47 thousand -63.8%0.1%0.2 $1.76
4/15/202333,700 shares $64.03 thousand +163.3%0.2%0.7 $1.90
3/31/202312,800 shares $25.47 thousand -25.6%0.1%0.3 $1.99
3/15/202317,200 shares $31.99 thousand -51.6%0.1%0.3 $1.86
2/28/202335,500 shares $77.75 thousand -47.6%0.2%0.7 $2.19
2/15/202367,700 shares $176.70 thousand +35.4%0.4%1.2 $2.61
1/31/202350,000 shares $115.00 thousand -40.7%0.3%0.8 $2.30
1/15/202384,300 shares $182.09 thousand +28.9%0.5%1.3 $2.16
12/30/202265,400 shares $75.21 thousand +127.9%0.4%1.1 $1.15
12/15/202228,700 shares $40.47 thousand +25.3%0.2%0.5 $1.41
11/30/202222,900 shares $35.95 thousand +2.7%0.1%0.4 $1.57
Here’s the stock symbol I’ve promised (Ad)

Whitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - but now he believes he's found something better. This under-the-radar company sits at the intersection of America's two most important industries, including AI, pays massive dividends, and attracted a famous money manager who put 60% of his multi-billion-dollar fund into it. Tilson is revealing the name and ticker symbol completely free - no credit card or email required.tc pixel

Get the stock name and ticker symbol free of charge today
11/15/202222,300 shares $40.14 thousand -0.5%0.1%0.3 $1.80
10/31/202222,400 shares $45.02 thousand -47.5%0.1%0.3 $2.01
10/15/202242,700 shares $81.34 thousand -17.3%0.3%0.7 $1.91
9/30/202251,600 shares $97.52 thousand +32.3%0.3%0.9 $1.89
9/15/202239,000 shares $95.16 thousand -14.5%0.2%0.7 $2.44
8/31/202245,600 shares $98.04 thousand -9.7%0.3%0.8 $2.15
8/15/202250,500 shares $108.58 thousand -0.4%0.3%0.5 $2.15
7/31/202250,700 shares $81.63 thousand -11.1%0.3%0.5 $1.61
7/15/202257,000 shares $100.32 thousand +325.4%0.4%0.5 $1.76
6/30/202213,400 shares $23.18 thousand -68.2%0.1%0.1 $1.73
6/15/202242,100 shares $73.68 thousand -17.8%0.3%0.4 $1.75
5/31/202251,200 shares $67.07 thousand +85.5%0.3%0.4 $1.31
5/15/202227,600 shares $39.19 thousand +17.0%0.3%0.4 $1.42
4/30/202223,600 shares $39.65 thousand -60.9%0.2%0.4 $1.68
4/15/202260,300 shares $151.35 thousand +1.3%0.6%0.9 $2.51
3/31/202259,500 shares $130.90 thousand -35.0%0.6%0.8 $2.20
3/15/202291,500 shares $167.45 thousand +37.6%0.9%0.9 $1.83
2/28/202266,500 shares $123.03 thousand -26.4%0.6%0.5 $1.85
2/15/202290,300 shares $190.53 thousand -24.0%0.8%0.7 $2.11
1/31/2022118,800 shares $285.12 thousand +52.3%1.3%0.7 $2.40
1/15/202278,000 shares $188.76 thousand -41.7%N/A0 $2.42
12/31/2021133,700 shares $405.11 thousand +188.2%1.4%0.7 $3.03
12/15/202146,400 shares $110.43 thousand -16.3%0.5%0.2 $2.38
11/30/202155,400 shares $156.23 thousand -0.7%0.6%0.4 $2.82
11/15/202155,800 shares $195.86 thousand -21.9%0.6%0.4 $3.51
10/29/202171,400 shares $235.62 thousand +152.3%0.8%0.4 $3.30
10/15/202128,300 shares $96.79 thousand -41.4%0.3%0.2 $3.42
9/30/202148,300 shares $173.40 thousand -42.0%0.5%0.3 $3.59
9/15/202183,200 shares $348.61 thousand -16.6%0.9%0.3 $4.19
8/31/202199,700 shares $443.67 thousand -26.2%1.1%0.1 $4.45

DMRA Short Interest - Frequently Asked Questions

Short interest is the volume of Damora Therapeutics, Inc. Common Stock shares that have been sold short but have not yet been covered or closed out. As of August 14th, traders have sold 4,739,939 shares of DMRA short. 7.71% of Damora Therapeutics, Inc. Common Stock's shares are currently sold short. Learn More on Damora Therapeutics, Inc. Common Stock's current short interest.

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. DMRA shares currently have a short interest ratio of 13.6. Learn More on Damora Therapeutics, Inc. Common Stock's short interest ratio.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 7.71% of Damora Therapeutics, Inc. Common Stock's floating shares are currently sold short.

Damora Therapeutics, Inc. Common Stock saw a decrease in short interest in August. As of August 14th, there was short interest totaling 4,739,939 shares, a decrease of 3.1% from the previous total of 4,893,454 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

7.71% of Damora Therapeutics, Inc. Common Stock's shares are currently sold short. Here is how the short interest of companies in the industry of "biotechnology" compare to Damora Therapeutics, Inc. Common Stock: Scholar Rock Holding Corporation (16.68%), CG Oncology, Inc. (13.33%), Oruka Therapeutics, Inc. (16.39%), Cogent Biosciences, Inc. (11.36%), Mirum Pharmaceuticals, Inc. (10.90%), Kiniksa Pharmaceuticals International, plc (11.43%), Erasca, Inc. (10.28%), Travere Therapeutics, Inc. (13.26%), Dianthus Therapeutics, Inc. (15.88%), PTC Therapeutics, Inc. (12.93%),

As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($71.57 billion), Invesco QQQ ($46.97 billion), iShares Russell 2000 ETF ($24.02 billion), Nebius Group N.V. ($15.37 billion), Sandisk Corporation ($12.60 billion), SPDR S&P Biotech ETF ($12.14 billion), Western Digital Corporation ($10.32 billion), iShares 20+ Year Treasury Bond ETF ($8.38 billion), VanEck Semiconductor ETF ($7.62 billion), and iShares iBoxx $ High Yield Corporate Bond ETF ($7.07 billion). View all of the most shorted stocks.

Short selling DMRA is an investing strategy that aims to generate trading profit from Damora Therapeutics, Inc. Common Stock as its price is falling. DMRA shares are trading down $1.60 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Damora Therapeutics, Inc. Common Stock occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of DMRA, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including DMRA, twice per month. The most recent reporting period available is August, 14 2026.

Understanding short interest metrics can help you assess how traders are positioning around a stock like DMRA:

  • Shares Sold Short: The total number of shares that have been sold by short sellers but have not yet been covered or closed out. A high number may indicate bearish sentiment.
  • Short Float: The percentage of a company’s publicly available shares (or "float") that are sold short. A higher short float suggests a greater portion of the stock is being bet against.
  • Days to Cover (Short Interest Ratio): This estimates how many days it would take short sellers to cover their positions, based on average daily trading volume. Higher values can signal potential for a short squeeze if buying pressure increases.

These metrics are often used by traders to gauge sentiment, volatility risk, and the potential for price movements based on short covering activity.



Short interest data for NASDAQ:DMRA is sourced from the Financial Industry Regulatory Authority (FINRA), with the most recent report published on 8/25/2026. FINRA publishes updated short interest twice a month.
From Our Partners